
Levels of Rectal Mucosal Polyamines and Prostaglandin E2 Predict Ability of DFMO and Sulindac to Prevent Colorectal Adenoma
Keywords: Biomarkers; Chemoprevention; Colorectal Cancer; CI; confidence interval; COX; cyclooxygenase; CRA; colorectal adenoma; CV; coefficient of variation; DFMO; difluoromethylornithine; NSAID; nonsteroidal anti-inflammatory drug; ODC; ornithine decarboxylase; P